This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/4/705    most recent 01.ATV.0000261709.34878.20v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwartz, S. M. Articles by Falk, E. Search for Related Content PubMed PubMed Citation Articles by Schwartz, S. M. Articles by Falk, E. Related Collections Related Article

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:705.)
© 2007 American Heart Association, Inc.

Brief Reviews

Plaque Rupture in Humans and Mice

Stephen M. Schwartz; Zorina S. Galis; Michael E. Rosenfeld; Erling Falk

From the Department of Pathology (S.M.S., M.E.R.), University of Washington, Seattle; the Indiana University and Lilly Research Laboratories (Z.S.G.), Indianapolis; and the Department of Cardiology (E.F.), University of Aarhus, Denmark.

Correspondence to Stephen M. Schwartz, Department of Pathology, 815 Mercer Street, Room 421, University of Washington, Seattle, WA 98109-4714. E-mail steves{at}u.washington.edu

Despite the many studies of murine atherosclerosis, we do not yet know the relevance of the natural history of this model to the final events precipitated by plaque disruption of human atherosclerotic lesions. The literature has become particularly confused because of the common use of terms such as "instability", "vulnerable", "rupture", or even "thrombosis" for features of plaques in murine model systems not yet shown to rupture spontaneously and in an animal surprisingly resistant to formation of thrombi at sites of atherosclerosis. We suggest that use of conclusory terms like "vulnerable" and "stable" should be discouraged. Similarly, terms such as "buried fibrous caps" that imply preceding events that are unproven tend to create confusion. We will argue that such terminology may mislead readers by implying knowledge that does not yet exist. We suggest, instead, a focus on specific processes that various forms of data have implicated in plaque progression. For example, formation of the fibrous cap, protease activation, and cell death in the necrotic core can be well described and have all been modeled in well-defined experiments. The relevance of such well-defined, objective, descriptive observations in the mouse can be tested for relevance against data from human pathology.

Despite the many studies of murine atherosclerosis, we do not yet know the relevance of the natural history of this model to the final events precipitated by plaque disruption of human atherosclerotic lesions. The literature has become particularly confused because of the common use of terms such as "instability", "vulnerable", "rupture", or even "thrombosis" for features of plaques in murine model systems not yet shown to rupture spontaneously and in an animal surprisingly resistant to formation of thrombi at sites of atherosclerosis. We will argue that such terminology may mislead readers by implying knowledge that does not yet exist.

Key Words: plaque rupture • murine atherosclerosis • fibrous cap • vulnerable plaque • progression

Related Article:

Two Views on Plaque Rupture

Göran K. Hansson and Donald D. Heistad
Arterioscler Thromb Vasc Biol 2007 27: 697. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				E. Shantsila and G. Y.H. Lip Monocytes in Acute Coronary Syndromes Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1433 - 1438. [Abstract] [Full Text] [PDF]

				M Ni, W Q Chen, and Y Zhang Animal models and potential mechanisms of plaque destabilisation and disruption Heart, September 1, 2009; 95(17): 1393 - 1398. [Abstract] [Full Text] [PDF]

				J. W. Stevens and S. R. Lentz Countervailing Effects on Atherogenesis and Plaque Stability: A Paradoxical Benefit of Hypercoagulability? Circulation, September 1, 2009; 120(9): 722 - 724. [Full Text] [PDF]

				C. Cheng, A. M. Noordeloos, V. Jeney, M. P. Soares, F. Moll, G. Pasterkamp, P. W. Serruys, and H. J. Duckers Heme Oxygenase 1 Determines Atherosclerotic Lesion Progression Into a Vulnerable Plaque Circulation, June 16, 2009; 119(23): 3017 - 3027. [Abstract] [Full Text] [PDF]

				Z.-G. She, W. Zheng, Y.-S. Wei, H.-Z. Chen, A.-B. Wang, H.-L. Li, G. Liu, R. Zhang, J.-J. Liu, W. B. Stallcup, et al. Human Paraoxonase Gene Cluster Transgenic Overexpression Represses Atherogenesis and Promotes Atherosclerotic Plaque Stability in ApoE-Null Mice Circ. Res., May 22, 2009; 104(10): 1160 - 1168. [Abstract] [Full Text] [PDF]

				Z.-S. Shi, L. Feng, X. He, A. Ishii, J. Goldstine, H.V. Vinters, and F. Vinuela Vulnerable Plaque in a Swine Model of Carotid Atherosclerosis AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 469 - 472. [Abstract] [Full Text] [PDF]

				B. J. Bennett, S. S. Wang, X. Wang, X. Wu, and A. J. Lusis Genetic Regulation of Atherosclerotic Plaque Size and Morphology in the Innominate Artery of Hyperlipidemic Mice Arterioscler Thromb Vasc Biol, March 1, 2009; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]

				J. J. Manning-Tobin, K. J. Moore, T. A. Seimon, S. A. Bell, M. Sharuk, J. I. Alvarez-Leite, M. P.J. de Winther, I. Tabas, and M. W. Freeman Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 19 - 26. [Abstract] [Full Text] [PDF]

				C. P. Hans, M. Zerfaoui, A. S. Naura, A. Catling, and A. H. Boulares Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability Cardiovasc Res, June 1, 2008; 78(3): 429 - 439. [Abstract] [Full Text] [PDF]

				M. Levi and E. Stroes Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events Cardiovasc Res, June 1, 2008; 78(3): 407 - 408. [Full Text] [PDF]

				F. Johansson, F. Kramer, S. Barnhart, J. E. Kanter, T. Vaisar, R. D. Merrill, L. Geng, K. Oka, L. Chan, A. Chait, et al. Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice PNAS, February 12, 2008; 105(6): 2082 - 2087. [Abstract] [Full Text] [PDF]

				R. J. Petrovan, Y. Yuan, and L. K. Curtiss Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice J. Lipid Res., February 1, 2008; 49(2): 429 - 437. [Abstract] [Full Text] [PDF]

				G. Davi and C. Patrono Platelet Activation and Atherothrombosis N. Engl. J. Med., December 13, 2007; 357(24): 2482 - 2494. [Full Text] [PDF]

				W. Q. Chen, L. Zhang, Y. F. Liu, L. Chen, X. P. Ji, M. Zhang, Y. X. Zhao, G. H. Yao, C. Zhang, X. L. Wang, et al. Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2836 - H2844. [Abstract] [Full Text] [PDF]

				J. F. Bentzon, C. S. Sondergaard, M. Kassem, and E. Falk Smooth Muscle Cells Healing Atherosclerotic Plaque Disruptions Are of Local, Not Blood, Origin in Apolipoprotein E Knockout Mice Circulation, October 30, 2007; 116(18): 2053 - 2061. [Abstract] [Full Text] [PDF]

				G. K. Hansson and D. D. Heistad Two Views on Plaque Rupture Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 697 - 697. [Full Text] [PDF]

				C. L. Jackson Defining and Defending Murine Models of Plaque Rupture Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 973 - 977. [Full Text] [PDF]